Lapatinib

epidermal growth factor receptor ; Rattus norvegicus







11 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33727095 Lapatinib ditosylate rescues memory impairment in D-galactose/ovariectomized rats: Potential repositioning of an anti-cancer drug for the treatment of Alzheimer's disease. 2021 Jul 2
2 30260048 Individual or combination treatments with lapatinib and paclitaxel cause potential bone loss and bone marrow adiposity in rats. 2019 Mar 2
3 25283886 Lapatinib ameliorates experimental arthritis in rats. 2015 Feb 1
4 25055934 Determining the mechanisms of lapatinib-induced diarrhoea using a rat model. 2014 Sep 2
5 22948710 The dual-targeted HER1/HER2 tyrosine kinase inhibitor lapatinib strongly potentiates the cardiac myocyte-damaging effects of doxorubicin. 2013 Mar 4
6 21186272 Activation of the neuregulin/ErbB system during physiological ventricular remodeling in pregnancy. 2011 Mar 1
7 21791570 Lapatinib, a preventive/therapeutic agent against mammary cancer, suppresses RTK-mediated signaling through multiple signaling pathways. 2011 Aug 1
8 19850946 Role of epidermal growth factor inhibition in experimental pulmonary hypertension. 2010 Jan 15 1
9 20607690 Preclinical assessment of simultaneous targeting of epidermal growth factor receptor (ErbB1) and ErbB2 as a strategy for cholangiocarcinoma therapy. 2010 Sep 1
10 20664065 Decoupling of receptor and downstream signals in the Akt pathway by its low-pass filter characteristics. 2010 Jul 27 1
11 14633707 Epidermal growth factor receptor autocrine signaling in RIE-1 cells transformed by the Ras oncogene enhances radiation resistance. 2003 Nov 15 5